(Click the image above for more information about the event and participating companies)


KEYNOTES & JAPANESE COMPANY PITCHES

REGISTER FOR
KEYNOTE & PITCH SESSION

B2B MEETINGS WITH JAPANESE COMPANIES

Wednesday-Thursday
July 14-15, 2021
5:00 - 6:30 PM PDT

Deadline:

Tuesday, July 13, 2021

5:00 PM PDT

Please contact Japanese companies via the E-mail listed to arrange a meeting


Pitch Session

Thursday, July 15, 2021



Hisanori Matsui, PhD.

Neuroscience Pipeline Sustainability & Partnership

E-mailLinkedIn

Takeda Pharmaceutical Company Limited


Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company with 240 years of history. Neuroscience is a core therapeutic area for Takeda. Our focused diseases are age-related neurological disorders, hereditary neurological disorders and neuromuscular disorders. We need innovation enablers which include brain and muscle shuttle/delivery, patient segmentation and disease classification, and human-based Neuroscience research platform. From the initial idea to the launch of the medicine we are committed to working in partnership with external experts who share our vision and possess the knowledge and scientific capabilities to make truly transformative medicines for the patients we serve.

Takeda HP / LinkedIn / Twitter / YouTube